Concepedia

David Urech

DU

12

Publications

424

Citations

11

H-Index

2003

Active since

Affiliations

University of Geneva(Current)

University of Lausanne

Agile Therapeutics (United States)

David Urech is an author at University of Geneva specializing in medicine, cell signaling, and cytoskeleton.

ORCID

Top concepts

Publications per year

2003–2024

12

Publications

12

Relative Contribution of VEGF and TNF-α in the Cynomolgus Laser-Induced CNV Model: Comparing the Efficacy of Bevacizumab, Adalimumab, and ESBA105

Peter Lichtlen, Tim T. Lam, T. Michael Nork et al. · Investigative Ophthalmology & Visual Science · 2010 · 71 citations

Anti-inflammatory and cartilage-protecting effects of an intra-articularly injected anti-TNFα single-chain Fv antibody (ESBA105) designed for local therapeutic use

David Urech, Ulrich Feige, Stefan Ewert et al. · Annals of the Rheumatic Diseases · 2009 · 64 citations

Generic Approach for the Generation of Stable Humanized Single-chain Fv Fragments from Rabbit Monoclonal Antibodies

Leo Borras, Tea Gunde, Julia Tietz et al. · Journal of Biological Chemistry · 2010 · 63 citations · Full text

Pharmacokinetics and Posterior Segment Biodistribution of ESBA105, an Anti–TNF-α Single-Chain Antibody, upon Topical Administration to the Rabbit Eye

Esther Furrer, Marianne Berdugo, Cinzia Stella et al. · Investigative Ophthalmology & Visual Science · 2009 · 57 citations

Intranasal delivery of ESBA105, a TNF-alpha-inhibitory scFv antibody fragment to the brain

Esther Furrer, Valérie Hulmann, David Urech · Journal of Neuroimmunology · 2009 · 37 citations

, , +7

Rows per page

1–5 of 12